ArticleJournal of pharmacy & bioallied sciences2024
Effect of Polydopamine Nanoparticle-Induced Surface Modification on Demineralized Dentin for Enhanced Functional Remineralization.
Article in Journal of pharmacy & bioallied sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Evaluation of enamel remineralization potential and anticariogenic efficacy of polydopamine coated biogenic amorphous calcium phosphate.Clinical oral investigations · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Development of biomimetic nanomaterials for remineralization therapy is an important strategy in minimally invasive dentistry. The size of the therapeutic agent has a great influence on bioavailability, penetration ability, and larger surface area for interaction in hard tissue remineralization through the nonclassical crystallization pathway. This study aimed to comparatively evaluate the remineralization-inducing potential of polydopamine (PDA) and polydopamine nanoparticles (nPDs) on artificially demineralized dentin. Methodology: nPDs were prepared using commercially procured dopamine hydrochloride by the wet precipitation method. Obtained particles were characterized using scanning electron microscopy-energy-dispersive X-ray spectroscopy (SEM-EDX), transmission electron microscopy, particle size analysis and zeta potential determination via dynamic light scattering with a laser particle analyser, X-ray diffraction, X-ray photoelectron spectroscopy, and attenuated total reflectance Fourier transform infrared spectroscopy. The cytocompatibility of nPD and PDA was assessed by (3-(4,5-dimethythiazol-2-yl) 2,5-diphenyl tetrazolium bromide) assay on human dental pulpal stem cell lines. A total of 66 demineralized dentin slabs of 3 mm × 3 mm × 1 mm dimension were immersed in 2 mg/ml of freshly prepared PDA and nPD solutions for 12 hours, followed by reimmersion in calcium and phosphate solution at 37°C days for 10 days. Samples immersed in deionized water were used as a control group. All the specimens were subjected to various remineralization testing methods using SEM-EDX, Vicker's microhardness, and micro-Raman spectroscopic analysis. The Shapiro-Wilk test was used to assess the normality of the distribution, followed by one-way ANOVA for intergroup analysis and Results: nPD exhibited a nanospherical morphology with positive zeta potential. nPD revealed the polymeric amorphous nature with characteristic functional groups and exhibited >80% relative cell viability. nPD promoted superior remineralization ability by the formation of hydroxyapatite closely mirroring the Ca/P ratio of natural dentin with a hardness value significantly closer to the baseline, which was further evidenced by higher-intensity peaks of phosphate, amide, and proline on micro-Raman spectroscopic analysis. Conclusion: Dentin remineralization is more strongly facilitated by nanometric PDA than PDA, which has an enhanced functional remineralization effect.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.